
Sign up to save your podcasts
Or


By The Wall Street Journal & Spotify Studios
4.2
56105,610 ratings
The podcast currently has 1,848 episodes available.
The most played episodes among Podcast App listeners.

The U.S. and Canada are once again embroiled in a fight over tariffs. During negotiations last week, President Trump threatened big hikes. Canada retaliated with their own tariffs. WSJ’s Gavin Bade explains how trade negotiations between two countries broke down and what could come next. Ryan Knutson hosts. Further Listening: - Tariffs Are Back. What’s Changed? - Canada’s New Leader Is Ready To Take on Trump Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

The swings in the bond market this week had Wall Street scrambling. After bond yields hit a historic high the U.S. Treasury made a surprise announcement: it’s doubling the amount of long term debt it’s buying back. WSJ’s Greg Ip breaks it all down for us, explaining how bonds work, why yields have been on the rise and why we should all pay attention. Jessica Mendoza hosts. Further Listening: - Tariffs Are Back. What’s Changed? - The Dollar Is Weaker. Is That a Good Thing? Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Costco pays its hourly wage workers more than most retailers. The company says that this keeps turnover low and ultimately, is good for its business. WSJ’s Sarah Nassauer explains how this approach helps the company’s bottom line, and speaks to one Costco cashier who's been working there for 40 years and now has more than a million dollars saved for his retirement. Jessica Mendoza hosts. Further Listening: - Jersey Mike's Journey From the Shore to Wall Street - How IKEA Is Keeping Its Furniture Affordable Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

For years, Moderna was a one-hit wonder, a company that bet everything on mRNA, struck gold with a COVID vaccine and then watched its stock crater as the pandemic faded. Now, the company may have found a way to fight skin cancer. An experimental mRNA-based vaccine succeeded in preventing melanoma from returning in high-risk patients, sending drug industry stocks soaring. WSJ’s Xavier Martinez traces Moderna’s wild ride from scrappy startup to the frontier of cancer treatment. Ryan Knutson hosts. Further Listening: - The FDA Commissioner on Vaccines and Public Trust - The Creator of the Record-Setting Covid Vaccine Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Flock Safety, the company behind the AI-enabled street cameras, has grown into a multibillion-dollar surveillance giant over the last few years. Supporters say the cameras have helped police reduce crime and solve cases. But critics say they violate privacy rights and are easily misused. WSJ’s Kris Maher reports on recent Flock protests and how the company is responding to the backlash. Imani Moise hosts. Further Listening: - The Vanishing of an Anti-AI Activist - The ‘Class of AI’ Enters the Workforce Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
The podcast currently has 1,848 episodes available.

30,657 Listeners

2,828 Listeners

1,711 Listeners

4,337 Listeners

1,975 Listeners

1,650 Listeners

111,908 Listeners

673 Listeners

56,477 Listeners

1,427 Listeners

1,036 Listeners

5,203 Listeners

1,564 Listeners

156 Listeners

1,322 Listeners

585 Listeners

151 Listeners

144 Listeners